Ant International Deepens Payment and Digitalisation Ecosystem with AI-Driven Embedded Finance Solutions in Year of Transformation
6.12.2024 17:00:00 CET | Business Wire | Press release
Numbers show Alipay+ expands a vibrant wallet-based payment and digitalisation space that further strengthens WorldFirst and Antom, the two business fintech services.Starting with over 11 million underserved SMEs and individuals in Southeast Asia and South Asia, the new Embedded Finance segment deepens Ant International’s ecosystem by offering a rich array of FX, treasury management, inclusive lending and other AI-powered fintech solutions to clients and partners across the other three main businesses.
With a series of organisational and strategic upgrades in 2024, Ant International, a leading global digital payment and financial technology provider, reported robust growth over the past year among all its four pillar businesses, Alipay+, Antom, WorldFirst and Embedded Finance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241205425502/en/
(Graphic: Business Wire)
Alipay+ expanded its vibrant wallet-based payment and digitalisation space that further strengthens WorldFirst and Antom, the two business fintech services. The new Embedded Finance segment deepens Ant International's ecosystem by offering a rich array of FX, treasury management, inclusive lending and other AI-powered fintech solutions to clients and partners across the other three main businesses.
“2024 has been a transformative year for Ant International,” said Peng Yang, Chief Executive Officer of Ant International. “We are committed to advance inclusive growth through AI-powered innovation and collaboration on cross-border travel, trade, commerce and inclusive finance.”
Based in Singapore, Ant International provides partners across industries and markets a comprehensive range of digital payment and financial technology solutions. It is committed to driving inclusive growth through open collaboration and continuous innovation.
Among Ant International's notable progresses in 2024 so far:
Alipay+: Ant International’s cross-border mobile payment and digitalisation technology solutions.
- Alipay+ leads the industry in collaboration with 35 leading mobile payment partners, including e-wallets, banking apps and BNPL apps, etc., connecting over 90 million merchants in 66 markets to 1.6 billion user accounts. It has also formed strategic partnerships with national standardised QR schemes, such as Singapore’s SGQR, Malaysia’s PayNet, South Korea’s ZeroPay, Cambodia's KHQR, Nepal’s NepalPay QR and Sri Lanka's LankaPay.
- Among the global merchants accepting QR code payments via Alipay+, over 90% are SMEs, reflecting Ant International’s focus on inclusive digital transformation.
- Cross-border transactions of global payment partners together (excluding Alipay) via Alipay+ registered three times year-on-year increase in 2024, where Alipay maintains the leadership.
Alipay+ builds a broader digital payment and digitalisation ecosystem for other pillar businesses of Ant International.
Antom: a leading merchant payment and digitisation services provider, offering one-stop, vertical-specific digital payment solutions to merchants of all sizes.
- Total payment volume (TPV) of Antom’s direct acquiring services nearly doubled between January and November 2024 over same period of 2023.
- Antom continues to strengthen its payment processing capabilities across all payment channels. Antom’s card processing volume grew over 10 times from that of previous year, while delivering top notch authorization rates to its global enterprise merchants.
- Antom continues to launch tech-driven innovative solutions to provide more secure and efficient services at lower cost to its customers. Antom Copilot helped enhance operational efficiency for merchants by reducing the payment channel integration time from 5 to 10 days to only a few minutes. Antom EasySafePay streamlined digital wallet payments procedures, eliminating the need to redirect from merchant checkout page to the user’s wallet app, and offers full account takeover protection to wallet users, and lead to significant payment success rate increase.
WorldFirst: a one-stop digital payment and financial services platform for global businesses.
- In 2024, five years after its acquisition, WorldFirst achieved an annual TPV of US$100 billion, four times that of 2020. This marks its transformation into the world's leading one-stop digital payment and financial services platform for cross-border businesses.
- Accumulatively, WorldFirst has served more than 1 million SMEs globally, with a total TPV surpassing US$300 billion and an ever-strengthening growth momentum as it expands footprints from Asia and Europe to the rest of the world.
Under Embedded Finance, our Credit Tech and Platform Tech teams leverage cutting-edge AI and blockchain technologies to innovate secure, end-to-end embedded finance solutions to clients and partners across Alipay+, Antom and WorldFirst businesses, ranging from risk-modelling, cross-border settlement, FX and liquidity management, to credit and lending services for underserved SMEs and individuals.
- In line with G20's commitment to lower cross-border payment costs via technology innovation, Platform Tech developed a world-leading Time-Series Transformer AI FX Model to help multi-national merchants in airline, e-commerce and other sectors to improve treasury management efficiency and reduce cost. Our FX solutions predict real-time local currency needs by the hour, with an accuracy of over 90%, significantly lowering cost and uncertainty for not only our own operations but millions of merchants, including SMEs.
Through collaborative innovation with global financial institutions, we leverage blockchain technology to provide 24/7 real-time cross-border settlement serviceability to our global business and clients. In 2024, the blockchain solution supported over one third of Ant International's total processing volume.
- In 2024, leveraging AI-powered Credit Tech and Risk Tech capabilities, Ant International added to ANEXT Bank, its Singapore-based MSME-focused digital bank, a new inclusive credit service under the brand bettr. Today in emerging markets including Bangladesh and Indonesia, bettr collaborates with local fintech partners to enable over 11 million unserved micro businesses and individuals, most first-time borrowers, to acquire uncollateralized loan services based on more accurate and fairer credit ratings.
- In 2024, loans under management across Ant International's SME financing services more than doubled compared to 2023.
“In 2025, we will continue to be laser-focused on supporting SMEs across borders with AI-powered innovative and trusted payment, digitalisation, and inclusive financing solutions through expanded public- and private-sector collaboration,” said Yang.
About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241205425502/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom